drugset
drugset / Trial / NCT01728246

An Efficacy, Safety and Effects on Quality of Life of Tramadol/Paracetamol as Add-on Therapy in Chronic Osteoarthritis

NCT01728246 ↗

Phase 4 Completed 473 enrolled Janssen Pharmaceutica
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy, safety and effects on Quality of Life (QOL) of tramadol/paracetamol (APAP) as an add-on therapy (medication taken in addition to another medication) in Filipino participants with chronic (lasting a long time) osteoarthritis (disorder, which is seen mostly in older persons, in which the joints become painful and stiff).

Timeline

Start
2007-10
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 325 mg —
Subject Tramadol Other / unclassified 37.5 mg —
Background Celecoxib Other / unclassified 200 mg —

Indications

osteoarthritis